Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Köhler, Anton ^a   Sarkkinen, Essi ^b,c   Tapola, Niina ^b   Niskanen, Tarja ^b   Bruheim, Inge ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b Oy foodfiles Ltd   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Olympic Seafood ^*  (Norway)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Krill meal; Krill oil; Omega 3 fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; EDIBLE OIL; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; KRILL OIL; PHOSPHOLIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; OIL;

ADULT; AGED; ALCOHOL CONSUMPTION; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; EXERCISE; FEMALE; HUMAN; KRILL; LIPID COMPOSITION; MALE; MEAL; PHOSPHOLIPID BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TRIACYLGLYCEROL BLOOD LEVEL; WALKING; ANIMAL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; MIDDLE AGED;

EUPHAUSIACEA;

ANIMALS; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EUPHAUSIACEA; FATTY ACIDS; FEMALE; FISH OILS; HUMANS; MALE; MIDDLE AGED; OILS; PHOSPHOLIPIDS; SINGLE-BLIND METHOD; TRIGLYCERIDES;

EID: 84925867318     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0015-4     Document Type: Article

References (19)

1. von Schacky C. Omega-3 Fatty Acids in Cardiovascular Disease-an Uphill Battle. Prostagland Leukotr Ess Fatty Acids. 2015;92:41-7.
2. Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab. 2008;33:228-89.
3. Lane K, Derbyshire E, Li W, Brennan C. Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature. Crit Rev Food Sci Nutr. 2014;54:572-9.
4. Ulven SM, Kirkhus B, Lamglait A, Basu S, Elind E, Haider T, et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 2011;46:37-46.
5. Schuchardt JP, Hahn A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2013;89:1-8.
6. Davidson MH, Johnson J, Rooney MW, Kyle ML, Kling DF. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study. J Clin Lipidol. 2012;6:573-84.
7. Maki KC, Reeves MS, Farmer M, Griinari M, Berge K, Vik H, et al. Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res. 2009;29:609-15.
8. Schuchardt JP, Schenider I, Mayer H, Neubronner J, Von Schacky C, Hahn A. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations-a comparative bioavailability study of fish oil vs. krill oil. Lipids Health Dis. 2011;10:145.
9. Harris WS, Varvel SA, Pottala JV, Warnick GR, McConnell JP. The Comparative Effects Of An Acute Dose Of Fish Oil On Omega-3 Fatty Acid Levels in Red Blood Cells Versus Plasma: Implications for Clinical Utility. J Clin Lipidol. 2013;7:433-40.
10. von Schacky C, Weber PC. Metabolism and Effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest. 1985;76:2446-50.
11. Sarkkinen ES, Ågren JJ, Ahola I, Ovaskainen M-L, Uusitupa MIJ. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicator of adherence to fat-modified diets. Am J Clin Nutr. 1994;59:364-70.
12. Matthan NR, Ip B, Resteghini N, Ausma LM, Lichtenstein AH. Long-term fatty acid stability in human serum cholesteryl-ester, triglyceride, and phospholipid fractions. J Lipid Res. 2010;51:2826-32.
13. Ramprasath VR, Eyal I, Zchut S, Jones PJ. Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis. 2013;5(12):178.
14. Salem Jr N, Kuratko CN. A reexamination of krill oil bioavailability studies. Lipids Health Dis. 2014;26(13):137.
15. Laidlaw M, Cockerline CA, Rowe WJ. A randomized clinical trial to determine the efficacy of manufacturers' recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction. Lipids Health Dis. 2014;21(13):99.
16. Araujo P, Zhu H, Breivik JF, Hjelle JI, Zeng Y. Determination and structural elucidation of triacylglycerols in krill oil by chromatographic techniques. Lipids. 2014;49:163-72.
17. Köhler A, Bittner D, Löw A, von Schacky C. Effects of a convenience drink fortified with n-3 fatty acids on the n-3 index. Br J Nutr. 2010;104:729-36.
18. Muhlhausler BS, Gibson RA, Yelland LN, Makrides M. Heterogeneity in cord blood DHA concentration: towards an explanation. Prostaglandins Leukot Essent Fatty Acids. 2014;91:135-40.
19. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348-80.